Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Imaging-guided prognostic score-based approach to assess the benefits of combotherapy versus monotherapy with immune checkpoint inhibitors in metastatic MSI-H colorectal cancer patients.
Barbe R, Belkouchi Y, Menu Y, Cohen R, David C, Kind M, Harguem S, Dawi L, Hadchiti J, Selhane F, Billet N, Ammari S, Bertin A, Lawrance L, Cervantes B, Hollebecque A, Balleyguier C, Cournede PH, Talbot H, Lassau N, Andre T. Barbe R, et al. Among authors: belkouchi y. Eur J Cancer. 2024 May;202:114020. doi: 10.1016/j.ejca.2024.114020. Epub 2024 Mar 16. Eur J Cancer. 2024. PMID: 38502988
Detection and severity quantification of pulmonary embolism with 3D CT data using an automated deep learning-based artificial solution.
Djahnine A, Lazarus C, Lederlin M, Mulé S, Wiemker R, Si-Mohamed S, Jupin-Delevaux E, Nempont O, Skandarani Y, De Craene M, Goubalan S, Raynaud C, Belkouchi Y, Afia AB, Fabre C, Ferretti G, De Margerie C, Berge P, Liberge R, Elbaz N, Blain M, Brillet PY, Chassagnon G, Cadour F, Caramella C, Hajjam ME, Boussouar S, Hadchiti J, Fablet X, Khalil A, Talbot H, Luciani A, Lassau N, Boussel L. Djahnine A, et al. Among authors: belkouchi y. Diagn Interv Imaging. 2024 Mar;105(3):97-103. doi: 10.1016/j.diii.2023.09.006. Epub 2023 Oct 11. Diagn Interv Imaging. 2024. PMID: 38261553
Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer.
Decazes P, Ammari S, Belkouchi Y, Mottay L, Lawrance L, de Prévia A, Talbot H, Farhane S, Cournède PH, Marabelle A, Guisier F, Planchard D, Ibrahim T, Robert C, Barlesi F, Vera P, Lassau N. Decazes P, et al. Among authors: belkouchi y. J Immunother Cancer. 2023 Sep;11(9):e007315. doi: 10.1136/jitc-2023-007315. J Immunother Cancer. 2023. PMID: 37678919 Free PMC article.
Detection and quantification of pulmonary embolism with artificial intelligence: The SFR 2022 artificial intelligence data challenge.
Belkouchi Y, Lederlin M, Ben Afia A, Fabre C, Ferretti G, De Margerie C, Berge P, Liberge R, Elbaz N, Blain M, Brillet PY, Chassagnon G, Cadour F, Caramella C, Hajjam ME, Boussouar S, Hadchiti J, Fablet X, Khalil A, Luciani A, Cotten A, Meder JF, Talbot H, Lassau N. Belkouchi Y, et al. Diagn Interv Imaging. 2023 Oct;104(10):485-489. doi: 10.1016/j.diii.2023.05.007. Epub 2023 Jun 14. Diagn Interv Imaging. 2023. PMID: 37321875
Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy.
Belkouchi Y, Talbot H, Lassau N, Lawrance L, Farhane S, Feki-Mkaouar R, Hadchiti J, Dawi L, Vibert J, Cournède PH, Cousteix C, Mazza C, Kind M, Italiano A, Marabelle A, Ammari S, Champiat S. Belkouchi Y, et al. Clin Cancer Res. 2023 Apr 14;29(8):1528-1534. doi: 10.1158/1078-0432.CCR-22-0890. Clin Cancer Res. 2023. PMID: 36719966
Synthetic MR image generation of macrotrabecular-massive hepatocellular carcinoma using generative adversarial networks.
Couteaux V, Zhang C, Mulé S, Milot L, Valette PJ, Raynaud C, Vlachomitrou AS, Ciofolo-Veit C, Lawrance L, Belkouchi Y, Vilgrain V, Lewin M, Trillaud H, Hoeffel C, Laurent V, Ammari S, Morand E, Faucoz O, Tenenhaus A, Talbot H, Luciani A, Lassau N, Lazarus C. Couteaux V, et al. Among authors: belkouchi y. Diagn Interv Imaging. 2023 May;104(5):243-247. doi: 10.1016/j.diii.2023.01.003. Epub 2023 Jan 20. Diagn Interv Imaging. 2023. PMID: 36681532 Free article.
Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs.
Decazes P, Ammari S, De Prévia A, Mottay L, Lawrance L, Belkouchi Y, Benatsou B, Albiges L, Balleyguier C, Vera P, Lassau N. Decazes P, et al. Among authors: belkouchi y. Diagnostics (Basel). 2023 Jan 5;13(2):205. doi: 10.3390/diagnostics13020205. Diagnostics (Basel). 2023. PMID: 36673015 Free PMC article.
Generative adversarial networks (GAN)-based data augmentation of rare liver cancers: The SFR 2021 Artificial Intelligence Data Challenge.
Mulé S, Lawrance L, Belkouchi Y, Vilgrain V, Lewin M, Trillaud H, Hoeffel C, Laurent V, Ammari S, Morand E, Faucoz O, Tenenhaus A, Cotten A, Meder JF, Talbot H, Luciani A, Lassau N. Mulé S, et al. Among authors: belkouchi y. Diagn Interv Imaging. 2023 Jan;104(1):43-48. doi: 10.1016/j.diii.2022.09.005. Epub 2022 Oct 5. Diagn Interv Imaging. 2023. PMID: 36207277 Free article.
Prediction of Early Response to Immunotherapy: DCE-US as a New Biomarker.
Naccache R, Belkouchi Y, Lawrance L, Benatsou B, Hadchiti J, Cournede PH, Ammari S, Talbot H, Lassau N. Naccache R, et al. Among authors: belkouchi y. Cancers (Basel). 2022 Mar 4;14(5):1337. doi: 10.3390/cancers14051337. Cancers (Basel). 2022. PMID: 35267645 Free PMC article.